EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Metastasis‐Directed Surgery for Solitary Pulmonary Metastasis After Pembrolizumab in Urothelial Carcinoma: A Case Report

Kohji Takemura, Makoto Tanaka, Yosuke Hamada, Takahiro Karasaki iD, Kazushige Sakaguchi, Hironori Uruga, Shinji Urakami iD, Sakashi Fujimori, Keita Uchino

IJU Case Reports · 2026-07 · 9 (4)

DOI: 10.1002/iju5.70201 ↗

Kurz gefasst

Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 27.05.2026. Verfasst von Kohji Takemura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology Toranomon Hospital Minato-ku Tokyo Japan. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The role of metastasis‐directed therapy in urothelial carcinoma remains uncertain, particularly in the immune checkpoint inhibitor era. We report a case of solitary pulmonary metastasis that developed after a favorable response to pembrolizumab and was managed with metastasectomy. Case Presentation A 65‐year‐old man with ureteral carcinoma underwent radical nephroureterectomy followed by adjuvant gemcitabine plus carboplatin. Three months later, a solitary pulmonary metastasis was detected and pembrolizumab was initiated. After initial enlargement, the lesion regressed and achieved a partial response after 13 cycles, followed by slight regrowth after 18 cycles, consistent with oligoprogression. Video‐assisted thoracoscopic metastasectomy was performed 14 months after pembrolizumab initiation. Pembrolizumab was continued for 1 year postoperatively, with no recurrence observed 17 months after surgery.

Conclusion

This case suggests that metastasis‐directed therapy may be a reasonable option for carefully selected patients with oligoprogressive urothelial carcinoma during immune checkpoint inhibitor therapy.

Schlagwörter

Stichwörter der Autor:innen

metastasis‐directed therapyoligometastasispembrolizumabpulmonary metastasectomyurothelial carcinoma

Autor:innen und Institutionen

  • Department of Medical Oncology Toranomon Hospital Minato-ku Tokyo Japan.
  • Department of Urology Toranomon Hospital Minato-ku Tokyo Japan.
  • Department of Thoracic Surgery, Respiratory Center Toranomon Hospital Minato-ku Tokyo Japan.
  • Department of Pathology Toranomon Hospital Minato-ku Tokyo Japan.

ORCID-Profile: Takahiro Karasaki, Shinji Urakami

Zitieren

APA

Takemura, K., Tanaka, M., Hamada, Y., Karasaki, T., Sakaguchi, K., Uruga, H., Urakami, S., Fujimori, S., & Uchino, K. (2026). Metastasis‐Directed Surgery for Solitary Pulmonary Metastasis After Pembrolizumab in Urothelial Carcinoma: A Case Report. IJU Case Reports, 9(4). https://doi.org/10.1002/iju5.70201

Vancouver

Takemura K, Tanaka M, Hamada Y, Karasaki T, Sakaguchi K, Uruga H, et al. Metastasis‐Directed Surgery for Solitary Pulmonary Metastasis After Pembrolizumab in Urothelial Carcinoma: A Case Report. IJU Case Reports. 2026;9(4). doi:10.1002/iju5.70201

BibTeX
@article{Takemura2026,
  author = {Takemura, Kohji and Tanaka, Makoto and Hamada, Yosuke and Karasaki, Takahiro and Sakaguchi, Kazushige and Uruga, Hironori and Urakami, Shinji and Fujimori, Sakashi and Uchino, Keita},
  title = {Metastasis‐Directed Surgery for Solitary Pulmonary Metastasis After Pembrolizumab in Urothelial Carcinoma: A Case Report},
  journal = {IJU Case Reports},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.1002/iju5.70201}
}
Kostenlos starten →